RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Verition Fund Management LLC's Holding History (CIK: 0001454027)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 412,747 Value ($000) $1,688 Avg Close $4.95 Range $3.81 - $7.18

Q3 2025

Shares 54,578 Value ($000) $266 Avg Close $5.25 Range $4.45 - $7.15

Q2 2025

Shares 223,216 Value ($000) $1,129 Avg Close $4.91 Range $3.79 - $6.11

Q1 2025

Shares 109,513 Value ($000) $579 Avg Close $7.29 Range $5.19 - $12.36

Q1 2023

Shares 33,400 Value ($000) $223 Avg Close $7.93 Range $6.40 - $9.73

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	412,747	$1,688	$4.95	$3.81 - $7.18
Q3 2025	54,578	$266	$5.25	$4.45 - $7.15
Q2 2025	223,216	$1,129	$4.91	$3.79 - $6.11
Q1 2025	109,513	$579	$7.29	$5.19 - $12.36
Q1 2023	33,400	$223	$7.93	$6.40 - $9.73